Novokon Pharmaceuticals Private Limited

Novokon Pharmaceuticals Private Limited - pharma in Greater Noida, Uttar Pradesh, India. FY 2026 financials & compliance.
CIN U24304UP2019PTC114615 Incorporated 13 March 2019 ROC Uttar Pradesh HQ Greater Noida, Uttar Pradesh, India
Active Private Limited Company pharma MSME · Micro
Revenue · FY 2025
₹64.59 Lakh
▼ 45% YoY
Net loss · FY 2025
₹10,311
Net margin -0.2%
EBITDA · FY 2025
₹7.6 Lakh
EBITDA margin 11.8%
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹1.5 Lakh
Issued & subscribed
Company age
7 yrs
Est. 2019
Employees · EPFO
2
Provident fund records
Directors on board
2
As per MCA filings

About Novokon Pharmaceuticals Private Limited

Data last updated:

Novokon Pharmaceuticals Private Limited is a private limited company based in Greater Noida, Uttar Pradesh, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 13 March 2019 and has been in existence for over 7 years.

The company is registered with the Registrar of Companies (ROC), Uttar Pradesh, under CIN U24304UP2019PTC114615. Its GSTIN is 09AAGCN4490G2Z6 (Uttar Pradesh). The company holds 2 GST registrations, of which 1 is active.

The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1.5 Lakh. It is led by directors Krishna Kumar Pandey and Anil Kumar Pandey.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at C – 1803 Divyansh Flora Gaur City – 2, Greater Noida, Uttar Pradesh, India – 201301.

As per the financials filed for FY 2025, the company reported a revenue of ₹64.59 Lakh, a decline of 45% compared to the previous year. For the same year it recorded a net loss of ₹10,311 (net margin -0.2%) and EBITDA of ₹7.6 Lakh (EBITDA margin 11.8%). Revenue has grown at a compounded annual rate (CAGR) of 9% over three years and 36% over five years.

The company has about 2 employees on its provident fund (EPFO) records.

Novokon Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-UP-32-0023066).

Company details

CIN U24304UP2019PTC114615
Registration Number 114615
Incorporation Date 13 March 2019
ROC Uttar Pradesh
Listing Status Unlisted
Company Status Active
MSME Classification Micro
Udyam Registration UDYAM-UP-32-0023066

Recognitions & Rankings of Novokon Pharmaceuticals

MSME (Udyam registered) Ministry of MSME
Category
Micro (2023-24)
Udyam number
UDYAM-UP-32-0023066

Contact details

Novokon Pharmaceuticals Private Limited's registered office is in Greater Noida, Uttar Pradesh. Its e-mail address is in the company report.

  • Email
  • Registered Address
    C – 1803 Divyansh Flora Gaur City – 2, Greater Noida, Uttar Pradesh, India – 201301
  • Industry
    Pharma, Pharmaceutical Retailers & Distributors

To see the full contact details of Novokon Pharmaceuticals Private Limited, buy the company report.

Comprehensive company report
Novokon Pharmaceuticals Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of Novokon Pharmaceuticals is trade. In detail, this covers wholesale trading.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
GTradeG1Wholesale Trading

To see the full business activity and turnover split of Novokon Pharmaceuticals Private Limited, buy the company report.

Financials of Novokon Pharmaceuticals Private Limited

FY 2025 filings available

Novokon Pharmaceuticals Private Limited reported revenue of ₹64.59 Lakh (down 45% YoY) for FY 2025.

Revenue · FY 2025
₹64.59 Lakh ▼ 45%
Net loss · FY 2025
₹10,311 margin -0.2%
EBITDA · FY 2025
₹7.6 Lakh margin 11.8%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▼ 45%
3 years · compounded
▼ 9%
5 years · compounded
▲ 36%
EBITDA CAGR growth
1 year
▼ 32%
3 years · compounded
▲ 59%
5 years · compounded
▲ 318%

Revenue fell 45% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 36%. EBITDA fell 32% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹7.6 Lakh
Profit Before Tax
Tax Expense
Net Profit (PAT)-₹10,311
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profitability
EBITDA Margin11.8%
Net Profit Margin-0.2%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Novokon Pharmaceuticals Private Limited, buy the company report.

Board of directors of Novokon Pharmaceuticals Private Limited

Novokon Pharmaceuticals has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Krishna Kumar PandeyDirector03 Apr 20215 Years 7 MonthsCurrent
Anil Kumar PandeyDirector13 Mar 20197 Years 8 MonthsCurrent

Peer comparison

Novokon Pharmaceuticals Private Limited is compared with the 7 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Akon Pharmaceuticals Private Limited₹65.2 Lakh (FY 2024)196.0%Surat, Gujarat, India
Zecon Pharmaceuticals Private Limited₹65.17 Lakh (FY 2024)-77.0%Lucknow, Uttar Pradesh, India
Aironax Pharmaceuticals Private Limited₹65.15 Lakh (FY 2025)138.0%Vadodara, Gujarat, India
Almonds Pharmaceuticals Private Limited₹65.07 Lakh (FY 2021)5.0%Kolar, Karnataka, India
Kyriz Pharmaceuticals Private Limited₹64.74 Lakh (FY 2024)Panchkula, Haryana, India
Novokon Pharmaceuticals Private Limitedthis company₹64.59 Lakh (FY 2025)-₹10,311-0.2%-45.0%2Greater Noida, Uttar Pradesh, India
Organic Pharmaceuticals Private Limited₹64.39 Lakh (FY 2025)16.0%New Delhi, Delhi, India
M.T Pharmaceuticals Private Limited₹64.22 Lakh (FY 2025)-24.0%Gorakhpur, Uttar Pradesh, India

To see the full peer comparison of Novokon Pharmaceuticals Private Limited, buy the company report.

Auditor

Novokon Pharmaceuticals Private Limited is audited by VIJAY PAREEK & CO for the financial year 2020.

Auditor firmFinancial yearFirm registration number
VIJAY PAREEK & COFY 2020021391C

Shareholding

The shareholding of Novokon Pharmaceuticals Private Limited is on record for FY 2020, split between promoters, domestic institutions, public shareholders and others.

Shareholder categoryFY 2020
Promoters
Domestic institutional investors (DII)
Public
Others

To see the full shareholding pattern of Novokon Pharmaceuticals Private Limited, buy the company report.

MSME payment delays

No delayed payments to MSME suppliers are on our record for Novokon Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

Employees & EPFO

Novokon Pharmaceuticals Private Limited has a workforce of 2 employees on its EPFO records as of Aug 2023, across 1 active EPFO establishment.

Employee count
2
Active EPFO establishments
1
Employee growth
-75%

Headcount by financial year

Financial yearEmployees (EPFO)
FY 2023-242
FY 2022-23

To see the full employee and EPFO history of Novokon Pharmaceuticals Private Limited, buy the company report.

GST

Novokon Pharmaceuticals has 2 GST registrations: 1 active and 1 cancelled or inactive.

Total GSTINs
2
Active
1
Cancelled / inactive
1
GSTINStateStatusRegistered on
09AAGCN4490G2Z6Uttar PradeshActive16 Dec 2019

To see the full GST registrations and return filing status of Novokon Pharmaceuticals Private Limited, buy the company report.

Recent activity

Novokon Pharmaceuticals Private Limited has 4 board changes on record since 2019: 2 appointments and 2 cessations. The latest: Naveen Kumar Srivastava ceased to be Director on 30 Apr 2021.

AGM
Novokon Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Novokon Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Uttar Pradesh Ii.
Ceased
Naveen Kumar Srivastava ceased to be Director.
Ceased
Sunil Kumar Gupta ceased to be Director.
Appointed
Krishna Kumar Pandey was appointed as Director.
Appointed
Anil Kumar Pandey was appointed as Director.
Incorporation
13 Mar 2019
Novokon Pharmaceuticals Private Limited was registered on 13 Mar 2019 with Roc Uttar Pradesh Ii & aged 7 years 8 months as per MCA records.

Frequently asked questions

Novokon Pharmaceuticals is an active private limited company based in Greater Noida, Uttar Pradesh, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 13 March 2019 (7+ years old) and is registered under CIN U24304UP2019PTC114615.

Novokon Pharmaceuticals has 2 current directors:

The latest financial statements of Novokon Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2019 are in the company report.

The GSTIN of Novokon Pharmaceuticals is 09AAGCN4490G2Z6, registered in Uttar Pradesh. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.

The CIN (Corporate Identification Number) of Novokon Pharmaceuticals is U24304UP2019PTC114615. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Novokon Pharmaceuticals was incorporated on 13 March 2019, making it 7+ years old. It is registered with the Registrar of Companies, Uttar Pradesh.

The peers of Novokon Pharmaceuticals by revenue are Akon Pharmaceuticals Private Limited, Zecon Pharmaceuticals Private Limited, Aironax Pharmaceuticals Private Limited, Almonds Pharmaceuticals Private Limited, Kyriz Pharmaceuticals Private Limited and 2 more, all in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading).

Naveen Kumar Srivastava ceased to be Director on 30 Apr 2021. Sunil Kumar Gupta ceased to be Director on 30 Apr 2021. Krishna Kumar Pandey was appointed as Director on 03 Apr 2021. Novokon Pharmaceuticals has 4 board changes on record in total.

Yes, Novokon Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-UP-32-0023066).

The registered office of Novokon Pharmaceuticals is at C – 1803 Divyansh Flora Gaur City – 2, Greater Noida, Uttar Pradesh, India – 201301.

Novokon Pharmaceuticals operates in the pharma industry, in the pharmaceutical retailers and distributors segment.